期刊文献+

抗N-甲基-D-天门冬氨酸受体脑炎发病机制的研究进展 被引量:1

Research advances in pathogenesis of anti-N-methyl-D-aspartate receptor encephalitis
原文传递
导出
摘要 抗N-甲基-D-天门冬氨酸受体(NMDAR)脑炎已经成为脑炎疾病当中最主要的类型。阐明抗NMDAR脑炎的发病机制对于理解该病,进而进行合理的治疗是非常有必要的。该文从以下几个方面进行综述:(1)抗NMDAR脑炎发病与肿瘤关系的发现;(2)抗NMDAR脑炎与肿瘤关系的进一步研究;(3)抗NMDAR抗体识别的抗原决定部位,患者的自身免疫反应;(4)抗体与受体的作用:(5)不伴有肿瘤的抗NMDAR脑炎的发病机制。该文向读者展示了这个病从在临床中被发现,到认识它和肿瘤的关系,再到从病理组织、分子水平以及信号传导水平进行研究的过程。展现一个科研思路,告诉读者临床医生是如何在临床中发现问题并逐步深入解决问题。目前的研究已证明抗NMDAR脑炎是一种和肿瘤尤其是卵巢畸胎瘤密切相关的神经系统自身免疫性疾病。 Anti-N-methyl-D-aspartate receptor(NMDAR) encephalitis is the most prevalent type of encephalitis.Investigating the pathogenesis of anti-NMDAR encephalitis will enhance our understanding of this disease and play a central part in providing reasonable treatment for the patients.The pathogenesis is elucidated as follows:(1) the findings of the relationship between anti-NMDAR encephalitis and tumors;(2) further research on the relationship between anti-NMDAR encephalitis and tumors;(3) NMDAR epitopes and the autoimmunity of patients;(4) the interaction between antibody and NMDAR;(5) the pathogenesis of anti-NMDAR encephalitis without tumors.This review gives a brief introduction to the methodology and way of finding out the valuable clinical problems and making a clear and explicit explanation of them by exhibiting the process of discovering the disease,disclosing its relationship with tumors,and investigating its pathological and molecular mechanism.Current studies have demonstrated that anti-NMDAR encephalitis is an autoimmune disease of the nervous system that is closely associated with tumors,particularly ovarian teratoma.[Chin J Contemp Pediatr,2014,16(6): 571-574]
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2014年第6期571-574,共4页 Chinese Journal of Contemporary Pediatrics
关键词 抗N-甲基-D-天门冬氨酸受体脑炎 发病机制 卵巢畸胎瘤 Anti-N-methyl-D-aspartate receptor encephalitis Pathogenesis Ovarian teratoma
  • 相关文献

参考文献17

  • 1Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project [J]. Clin Infect Diseases, 2012, 54(7): 899-904.
  • 2Titulaer M J, Mccracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti- NMDA receptor encephalitis: an observational cohort study [J].Lancet Neurol, 2013, 12(2): 157-165.
  • 3Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma[J]. Ann Neuro't, 2005, 58(4): 594-604.
  • 4Dalmau J, Tiiziin E, Wu HY, et al. Paraneoplastic anti-N- methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1): 25-36.
  • 5Mangler M, Trebesch de Perez I, Teegen B, et al. Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma[J]. J Neurol, 2013, 260(11): 2831-2835.
  • 6Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis[J]. J Neurol Neurosurg Psychiatiy, 2008, 79(3): 324-326.
  • 7Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies [J]. Lancet Neurol, 2008, 7(12): 1091-1098.
  • 8Tuzun E, Zhou L, Baehring JM, et al. Evidence for antibody- mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma [J]. Acta Neuropathol, 2009, 118(6): 737- 743.
  • 9Dabner M, Mecluggage WG, Bundell C, et al. Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 eases documenting prominent intratumoral lymphoid infiltrates [J]. Int J Gynecol Pathol, 2012, 31(5): 429-437.
  • 10Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis [J].Brain, 2012, 135(Pt 5): 1622-1638.

同被引文献14

  • 1Baguley IJ, Perkes IE, Fernandez-Ortega JK et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria[J]. J Neurotrauma, 2014, 31(17): 1515-1520.
  • 2Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti- NMDAR encephalitis[J]. Lancet Neurol, 2011, 10(1): 63-74.
  • 3Pryzbylkowski PG, Dunkman WJ, Liu R, et al. Case report: Anti-N-Methyl-D-Aspartate receptor encephalitis and its anesthetic implications[J]. Anesth Analg, 2011, 113(5): 1188-1191.
  • 4Hinson HE, Takahashi C, Altowaijri G, et al. Anti- NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association[J]. Clin Auton Res, 2013, 23(2): 109-111.
  • 5Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D- aspartate-receptor encephalitis: diagnosis, optimal management, and challenges[J]. Ther Clin Risk Manag, 2014, 10:517-525.
  • 6Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, et al. Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications[J]. J Neurotrauma, 2012, 29(7): 1364-1370.
  • 7Schroeppel TJ, Croce MA, Fabian TC. Re: Paroxysmal sympathetic hyperactivity, traumatic brain injury, and beta- blockers: Not all drugs are created equal[J]. J Trauma Acute Care Surg, 2014, 77(2): 387-388.
  • 8van de Riet EH, van Bronswijk SC, Schieveld JN. Movement disorders in anti-N-NMDA receptor encephalitis[J]. Tijdschr Psychiatr, 2015, 57(2): 109-113.
  • 9Baguley IJ. The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes[J]. Med Hypotheses, 2008, 70(1): 26-35.
  • 10Dalmau J, Gleichman A J, Hughes EG, et al. Anti-NMDA- receptor encephalitis: case series and analysis of the effects of antibodies[J]. Lancet Neurol, 2008, 7(12): 1091-1098.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部